Home

arrow iconArticlesarrow iconarrow icon

Understanding Ovarian Reserve Testing For Women

Understanding Ovarian Reserve Testing For Women

Ovarian reserve testing assesses how many eggs remain in your ovaries and your fertility potential. Learn about AMH, FSH, and antral follicle count tests, what results mean, and how this information guides fertility decisions and treatment planning.

By FertilityIn

11 May 2026

1 min read

Ovarian Reserve Testing

Ovarian Reserve Testing

Ovarian reserve testing is a fundamental part of fertility evaluation that helps you and your doctor understand your reproductive health. These tests measure how many eggs remain in your ovaries and assess the quality of your egg supply, which directly impacts your ability to conceive naturally or through fertility treatments like IVF. Whether you're planning your family or concerned about your fertility timeline, understanding ovarian reserve testing empowers you to make informed decisions about your reproductive future.


What Is Ovarian Reserve and Why Does It Matter?

Ovarian reserve refers to the total number of eggs (oocytes) remaining in your ovaries at any given time. Unlike men, who produce new sperm throughout their lives, women are born with a fixed number of eggs approximately 1–2 million at birth. This number naturally declines with age, and by the time you reach your reproductive years, you have roughly 300,000–400,000 eggs. As you age, this number continues to decrease, and equally important, the quality of your remaining eggs may decline.


Understanding your ovarian reserve helps fertility specialists and gynecologists determine whether you have sufficient eggs for natural conception, plan the timing of family-building, or decide if fertility preservation options like egg freezing are right for you. For those pursuing assisted reproductive technology (ART) procedures, ovarian reserve testing guides medication dosing and helps predict how your ovaries will respond to stimulation.



Ovarian reserve testing involves three primary assessments, each providing unique insights into your fertility. Here's what to expect during the process:


Step 1: The AMH Blood Test (Anytime During Your Cycle)

The Anti-Müllerian Hormone (AMH) test is a simple blood test that measures the level of AMH protein produced by cells surrounding your developing eggs. This is one of the most reliable markers of ovarian reserve.


  • What to expect: A healthcare professional will draw a small blood sample from a vein in your arm, a quick procedure that takes less than five minutes. The best part? You can take this test at any time during your menstrual cycle, without special preparation. Unlike other fertility hormones that fluctuate throughout the month, AMH remains relatively consistent, making it an ideal screening test.
  • How results are interpreted: Your AMH level reflects the size of your egg pool. Higher levels generally indicate more eggs available, while lower levels suggest fewer eggs remain in reserve. However, AMH doesn't measure egg quality, only quantity.


Step 2: The Day 3 FSH Test (Early in Your Cycle)

Follicle-Stimulating Hormone (FSH) is a hormone your pituitary gland produces to signal your ovaries to develop and release eggs. Testing FSH early in your cycle reveals important information about your ovarian reserve.


  • What to expect: Schedule a blood draw on Day 2 or Day 3 of your menstrual cycle (Day 1 is the first day of bleeding). The timing matters because FSH levels are at their baseline at this point in your cycle. As with the AMH test, you'll have a simple blood draw with no special preparation needed.
  • How results are interpreted: Lower FSH levels on Day 3 indicate good ovarian reserve, while elevated FSH suggests your body is working harder to stimulate egg development, a sign of diminished reserve. FSH levels vary by laboratory, so your doctor will compare your results to the reference ranges used by your specific lab.


Step 3: Antral Follicle Count (AFC) via Transvaginal Ultrasound (Days 2–3)

The antral follicle count uses ultrasound imaging to visualize and count the small follicles in your ovaries that contain developing eggs. This test provides a direct visual assessment of your egg supply.


  • What to expect: This procedure is performed during the early follicular phase of your cycle, ideally on Day 2 or Day 3. You'll lie on an examination table and a trained technician will gently insert a thin ultrasound probe (about the thickness of a finger) into your vagina. The probe emits harmless sound waves that create detailed images of your ovaries on a monitor. The procedure is quick, usually lasting 15–30 minutes, and is generally not painful, though some women may experience mild discomfort during the probe insertion.
  • How results are interpreted: The technician carefully counts all visible follicles measuring 2–10 millimeters in diameter in each ovary. A normal antral follicle count ranges from 5 to 15 follicles per ovary. Counts below 5 suggest reduced ovarian reserve, while counts above 15 indicate higher reserve.


Understanding Your Ovarian Reserve Testing Results

Interpreting your results requires considering all three tests together, along with your age and medical history. Results from ovarian reserve testing don't predict whether you'll get pregnant naturally they predict how your ovaries will respond to fertility medications and stimulation.


AMH levels vary significantly by age. In general:

  • Under age 25: 4.1–6.8 ng/mL indicates very high ovarian reserve
  • Ages 25–30: 2.9–5.8 ng/mL indicates high ovarian reserve
  • Ages 31–35: 1.5–4.0 ng/mL indicates normal ovarian reserve
  • Ages 36–40: 0.5–1.5 ng/mL indicates reduced ovarian reserve
  • Over age 40: Below 0.5 ng/mL indicates low ovarian reserve


An AMH level of 1.0–3.5 ng/mL is considered optimal for fertility treatment response. Values below 0.5 ng/mL suggest significantly diminished ovarian reserve, while values above 4.0 ng/mL in younger women may indicate a higher response to ovarian stimulation medications.



Day 3 FSH levels are interpreted as follows:

  • Less than 9 mIU/mL: Normal FSH level with good expected response to ovarian stimulation
  • 9–11 mIU/mL: Fair FSH level with variable response to stimulation
  • 11–25 mIU/mL: Elevated FSH suggesting reduced ovarian reserve
  • Over 25 mIU/mL: Very elevated FSH indicating significantly diminished ovarian reserve

It's important to note that a normal FSH level doesn't completely rule out diminished ovarian reserve. If your FSH is normal but your estradiol (E2) level is elevated (above 60–80 pg/mL), your estradiol may be artificially "suppressing" your FSH, masking a reduced reserve.


Antral Follicle Count Results Explained

AFC results are interpreted by counting follicles in both ovaries:

  • 15–30 follicles total: Good ovarian reserve
  • 12–25 follicles total: Normal ovarian reserve
  • 8–15 follicles total: Adequate ovarian reserve
  • Below 8 follicles total: Reduced ovarian reserve suggesting diminished reserve


What If Your Results Show Diminished Ovarian Reserve?

A diagnosis of diminished ovarian reserve (DOR) means you have fewer eggs than expected for your age. While this finding may feel concerning, it's important to understand what it does and doesn't mean.


What diminished ovarian reserve does NOT mean:

  • You cannot get pregnant naturally many people with low ovarian reserve conceive without medical intervention
  • You should immediately pursue fertility treatment
  • Your eggs are of poor quality (ovarian reserve testing measures only quantity, not quality)
  • Fertility treatment will not work for you


What diminished ovarian reserve means:

  • You may have a shorter window for family planning
  • Fertility treatment may benefit you if you're trying to conceive
  • Your doctor may recommend higher doses of fertility medications
  • Egg preservation through egg freezing might be worth considering
  • Additional testing may help clarify your fertility situation

Even with very low AMH levels or significantly reduced antral follicle counts, pregnancy is possible. Your fertility specialist can discuss personalized treatment options tailored to your specific situation.


When Should You Consider Ovarian Reserve Testing?

Ovarian reserve testing is recommended if:

  • You're over age 35 and planning to conceive within the next year
  • You have a family history of early menopause
  • You have irregular or absent menstrual periods
  • You've experienced unexplained infertility
  • You're considering egg freezing or fertility preservation
  • You have a medical history of cancer treatment, endometriosis, or ovarian surgery
  • You want baseline information about your fertility timeline before pursuing pregnancy
  • You're planning fertility treatment like IVF or intrauterine insemination (IUI)


Key Takeaways About Ovarian Reserve Testing

Ovarian reserve testing provides essential information to guide your fertility decisions. AMH blood testing, Day 3 FSH measurement, and antral follicle count ultrasound together give your doctor a comprehensive picture of your egg supply and how your ovaries might respond to fertility treatment. While these tests cannot predict whether you'll become pregnant naturally or through treatment, they help your healthcare team personalize your care and set realistic expectations.


Remember that ovarian reserve testing is just one part of your complete fertility evaluation. Your age, medical history, partner's fertility status (if applicable), and overall health all factor into your fertility potential. If you receive results indicating diminished ovarian reserve, schedule a detailed consultation with a fertility specialist to discuss your options and create a plan that aligns with your family-building goals.


DISCLAIMER: This content is for educational purposes only and not a substitute for professional medical advice, diagnosis, or treatment. Ovarian reserve results vary by individual, age, medical history, and lab standards. Always consult a qualified fertility specialist or gynecologist for accurate evaluation and guidance.

124 views

Share

FertilityIn

Send Enquiry for this Story

Previous Articles

Fertility Preservation Options Before Cancer Treatment

Next Articles

Transvaginal Oocyte Retrieval and Its Role in Enhancing IVF Outcomes

Related Articles

Spermatogonial Stem Cells and the Future of Fertility After Childhood Cancer

Spermatogonial Stem Cells and the Future of Fertility After Childhood Cancer

Boys treated for cancer before puberty cannot bank sperm, but freezing testicular tissue containing spermatogonial stem cells may one day restore their fertility. This article explains how the first transplants in adult survivors work, what the early research shows, the risks involved and why families should know about this option.

ART

1 min read

Microplastics in the Reproductive System and the Growing Fertility Concern

Microplastics in the Reproductive System and the Growing Fertility Concern

Microplastics have now been found in human follicular fluid and seminal fluid. This article explores the fast-growing body of research on microplastics and fertility, what scientists know and do not yet know about their effects on eggs and sperm, and practical, evidence-based ways that couples can reduce their everyday exposure.

ART

1 min read

Air Pollution and Its Potential Impact on Sperm Epigenetics and Male Fertility

Air Pollution and Its Potential Impact on Sperm Epigenetics and Male Fertility

Fertility conversations often focus on women, yet new research on sperm epigenetics shows a father's environment matters too. This article explains how air pollution may alter chemical marks on sperm DNA, why those changes could matter for fertility and pregnancy, and the practical steps men can reasonably consider before conception.

ART

1 min read

Uterine Ageing and the Role of Donor Eggs in Later-Life Pregnancy

Uterine Ageing and the Role of Donor Eggs in Later-Life Pregnancy

Donor eggs have long been seen as a way to reset the reproductive clock, but new research suggests uterine ageing also plays a role. This article explains what the latest evidence shows, how the ageing uterus may affect implantation and pregnancy, and how women in their late forties can prepare.

ART

1 min read

In Vitro Gametogenesis and the Future of Lab-Made Human Eggs

In Vitro Gametogenesis and the Future of Lab-Made Human Eggs

In vitro gametogenesis, the science of creating eggs and sperm from ordinary body cells, has moved from mouse studies towards human research. This article explains how the approaches work, what recent milestones really show, the obstacles that remain and why clinical use is still likely to be several years away.

ART

1 min read

Mitochondrial Donation Comes of Age: What Three-Parent IVF Means for Families With Inherited Disease

Mitochondrial Donation Comes of Age: What Three-Parent IVF Means for Families With Inherited Disease

Mitochondrial donation, often called three-parent IVF, has now produced the first detailed clinical results, with healthy children born to mothers at high risk of passing on mitochondrial disease. This article explains how the technique works, who it is for, what the evidence shows and which scientific questions remain open

ART

1 min read

AI Sperm Recovery: How Artificial Intelligence Is Finding Hidden Sperm in Men Told They Had None

AI Sperm Recovery: How Artificial Intelligence Is Finding Hidden Sperm in Men Told They Had None

A new AI sperm recovery technique is changing the outlook for men with azoospermia. This article explains how the STAR method scans semen samples for rare hidden sperm, what its first reported pregnancy means, who may benefit, and the key questions couples should raise with their own fertility specialist.

ART

1 min read

Landing Page Image

Subscribe to our Newsletter

Stay updated with the latest news, expert insights, and exclusive offers delivered straight to your inbox. Join our community today!

Email Address